abstract |
Disclosed are an EGFR kinase inhibitor and application thereof in preparing an anti-cancer drug; said EGFR kinase inhibitor reduces the alkalinity of EGFR TKI, can effectively improve the acquired drug resistance of EGFR TKI caused by the accumulation of SQSTM1, and is of great significance to improving the clinical treatment benefits of EGFR TKI. |